Lv51
1050 积分 2022-06-21 加入
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study
5天前
已完结
Advancements in neuroblastoma treatment: FDA-approved drugs and role of phytochemicals
18天前
已完结
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
1个月前
已完结
CAR-T therapy in solid tumors
2个月前
已完结
Naxitamab: First Approval
2个月前
已完结
Cancer therapy with antibodies
7个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
8个月前
已完结
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
9个月前
已完结
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
9个月前
已完结
皖公网安备34019202002308
